The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity.
Park S, Jiang Z, Mortenson ED, Deng L, Radkevich-Brown O, Yang X, Sattar H, Wang Y, Brown NK, Greene M, Liu Y, Tang J, Wang S, Fu YX.
Park S, et al. Among authors: yang x.
Cancer Cell. 2010 Aug 9;18(2):160-70. doi: 10.1016/j.ccr.2010.06.014.
Cancer Cell. 2010.
PMID: 20708157
Free PMC article.